TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06834165: Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

Sponsor: ARS Pharmaceuticals, Inc. · Phase: PHASE4 · Area: IMMUNOLOGY · Target Enrollment: 600 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$8,832,000

Rescue Site Savings

+$5,823,600

Unlock Full NCT06834165 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06834165 Rescue Dossier →